Conversion of recent-onset atrial fibrillation with intravenous amiodarone: A meta-analysis of randomized controlled trials

Pharmacotherapy

Volumn 22, Issue 1 I, 2002, Pages 66-74

  Hilleman, D E ^a   Spinler, S A ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF PHARMACY AND HEALTH PROFESSIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; DIGOXIN; DOFETILIDE; FLECAINIDE; IBUTILIDE; PLACEBO; PROCAINAMIDE; PROPAFENONE; QUINIDINE; QUINIDINE SULFATE; SOTALOL; VERAPAMIL;

BRADYCARDIA; CARDIOVERSION; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; HEART ATRIUM FIBRILLATION; HUMAN; HYPOTENSION; MEDICAL LITERATURE; META ANALYSIS; PHLEBITIS; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; SINUS RHYTHM;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BRADYCARDIA; COHORT STUDIES; HUMANS; HYPOTENSION; INJECTIONS, INTRAVENOUS; PHLEBITIS; RANDOMIZED CONTROLLED TRIALS;

EID: 0036137816     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.1.66.33492     Document Type: Short Survey

References (55)

1. Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implications
2. Epidemiologic features of chronic atrial fibrillation: The Framingham study
3. Atrial fibrillation: Epidemiology and the risk and prevention of stroke
4. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba follow-up study
5. Embolic complications in paroxysmal atrial fibrillation
6. Atrial fibrillation as an independent risk factor for stroke: The Framingham study
7. Atrial fibrillation and mortality in an elderly population
8. Atrial fibrillation follow-up investigation of rhythm management: The AFFIRM study design
9. Therapy of atrial fibrillation: Rhythm control versus rate control
10. Atrial fibrillation: Restoration and maintenance of sinus rhythm and indications for anticoagulation therapy
11. Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm: Relation to left atrial size
12. Comparison of flecainide and procainamide in cardioversion of atrial fibrillation
13. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation
14. Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm
15. Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm
16. Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease: A randomized, controlled trial
17. The value of class Ic antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm
18. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm
19. Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide
20. Efficacy of intravenous propafenone for the acute management of atrial fibrillation
21. Clinical course of recent-onset atrial fibrillation treated with oral propafenone
22. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation: Ibutilide repeat dose study investigators
23. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study
24. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter
25. Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter
26. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled study
27. Amiodarone
28. Efficacy, safety and determinants of conversion of atrial fibrillation and flutter with oral amiodarone
29. A clinical study of amiodarone as a single oral dose in patients with recent-onset atrial tachyarrhythmia
30. Propafenone versus amiodarone in field treatment of primary atrial tachydysrhythmias
31. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension
32. Management of atrial tachyarrhythmias in the critically ill: A comparison of intravenous procainamide and amiodarone
33. A comparison of amiodarone and digoxin for treatment of supraventricular arrhythmias after cardiac surgery
34. A comparison of amiodarone and digoxin in the treatment of atrial fibrillation complicating suspected acute myocardial infarction
35. Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation
36. Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation
37. A comparison of cardioversion of atrial fibrillation using oral amiodarone, intravenous amiodarone and DC cardioversion
38. Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study
39. The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery
40. Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm
41. Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations
42. Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm
43. Amiodarone versus quinidine for conversion of recent onset atrial fibrillation to sinus rhythm
44. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: The effect of no treatment and high dose amiodarone
45. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: Results of a randomized, controlled study
46. Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: A randomized controlled trial
47. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized controlled trials
48. The combination of estimates from different experiments
49. Meta-analysis in clinical trials
50. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation: The stroke prevention in atrial fibrillation investigators
51. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT
52. Randomized trial of low-dose amiodarone in severe congestive heart failure
53. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia
54. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm